EBS vs KEYS · rev $1.04B vs P/E 57, rev $4.98B
Emergent Biosolutions Inc (EBS) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
EBS currently screens at market cap $416.4M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the EBS and KEYS stock pages for the full models.
Not investment advice.